Cardiotonic drugs are a class of medications primarily designed to enhance the contractile force of the heart muscle and improve its pumping efficiency. These drugs play a crucial role in the management of various cardiovascular conditions, particularly heart failure. By increasing the strength of each heartbeat, cardiotonic drugs help improve cardiac output, ensuring that the heart effectively pumps blood throughout the body. Digoxin, a well-known cardiotonic drug, is derived from the foxglove plant and has been used for centuries. It works by inhibiting a sodium-potassium pump, leading to an increase in intracellular calcium concentration, which, in turn, strengthens myocardial contractions. While cardiotonic drugs can be beneficial in certain clinical scenarios, their use requires careful monitoring due to the narrow therapeutic window and potential for toxicity. In modern medicine, these drugs are often prescribed in combination with other cardiovascular medications to optimize treatment outcomes for patients with heart-related conditions.
Title : Pulse field ablation for atrial fibrillation complications: What do we know yet
Narendra Kumar, HeartbeatsZ Academy, United Kingdom
Title : The development of human relaxin-2 for heart failure with preserved ejection fraction, HFpEF
Thomas Bernd Dschietzig, Relaxera GmbH & Co. KG, Germany
Title : Cancer and cardiovascular diseases: Common pathogenesis mechanisms and risk factors
Mekhman N Mamedov, National Research Center for Preventive Medicine, Russian Federation
Title : Lipoprotein (a): The hidden cardiovascular risk
Syed Raza, Awali Hospital, Bahrain
Title : Innovative mechanisms, consequences and therapeutics for pulmonary hypertension
Yong Xiao Wang, Albany Medical College, United States
Title : Comprehensive surgical revascularization for rapidly worsening ischemic heart failure
Deepak Puri, Max Healthcare, India